Compounder dossier

blocked by partner

Promise Pharmacy

Promise is commercially active for clinics and telehealth providers, with a public 503A posture and clinic-facing portal story. It is useful for catalog coverage, but production API posture is still paperwork-gated.

Public facts

Promise publicly describes itself as an independently owned 503A compounding pharmacy.
Public site states 42 state licenses, LegitScript certification, third-party testing, and support for 600+ clinics.
Public FAQ says most orders ship within 24-72 hours, depending on medication type, verification, and account setup.

Routing rules

Do not expose portal/API claims publicly beyond confirmed onboarding and technical handoff state.
Represent Promise as 503A patient-specific compounding; any broader stock or wholesale language needs legal/provider review.

Source links

Promise About FDA letter

Local catalog notes

Master catalog has tiered pricing. Demo priceCents uses the 1-999 scripts price and preserves higher tiers in tags.
Business/MNDA workflow still needs partner follow-up before live integration.